Abstract:Programmed cell death (PCD) is an essential part of organismal development and plays fundamental roles in host defense against pathogens and the maintenance of homeostasis. However, excess activation of PCD pathways has proven to be detrimental and can drive disease. Additionally, resistance to PCD can also contribute to disease development. Modulation of PCD, therefore, has great therapeutic potential in a wide range of diseases, including infectious, neurodegenerative, autoinflammatory, and metabolic diseases and cancer. Nevertheless, manipulation of cell death and inflammation for therapeutic intervention is a delicate process, highly specific to the context of the disease of interest, making the selection of the appropriate target molecule crucially important. Several PCD pathways are associated with innate immunity, including pyroptosis, apoptosis, necroptosis, and PANoptosis, which is defined as an inflammatory PCD pathway with key features of pyroptosis, apoptosis, and/or necroptosis that cannot be accounted for by any of these three PCD pathways alone. All of these PCD pathways are regulated by upstream sensors and signaling cascades that assemble multimeric complexes to serve as activation platforms for downstream molecules; these sensors and signaling molecules provide attractive target points for therapeutic intervention. Here, we discuss the molecular mechanisms of innate immune-mediated cell death in health and disease, with a particular focus on the molecules putatively involved in the formation of the PANoptosome and the induction of inflammatory cell death. Further, we discuss the implications and feasibility of targeting these molecules to improve disease outcomes, as well as current clinical approaches.

Research Advances of the Relationship Between Caspase8 in Programmed Cell Death and Disease

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Caspase-8 in inflammatory diseases: a potential therapeutic target

Caspase-Mediated Programmed Cell Death Pathways As Potential Therapeutic Targets in Cancer

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview

Research progress on morphology and mechanism of programmed cell death

Caspase-8: A key protein of cross-talk signal way in "PANoptosis" in cancer

Progress in Programmed Cell Death Pathways

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

Programming inflammatory cell death for therapy

Programmed Cell Death and Cancer

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Emerging connectivity of programmed cell death pathways and its physiological implications

Molecular mechanism of pyroptosis and inflammasome activation

Research Progress of the Relationship Between Pyroptosis and Disease

Progress in Caspase-Like Proteases and Their Regulatory Roles in Programmed Cell Death in Plants

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases

Multiple roles of caspase‐8 in cell death, inflammation, and innate immunity

Programmed cell death in tumor immunity: mechanistic insights and clinical implications

The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death